NERV vs ENTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

NERV

40.3
AI Score
VS
NERV Wins

ENTX

39.7
AI Score

Investment Advisor Scores

NERV

40score
Recommendation
HOLD

ENTX

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV ENTX Winner
Net Income -8.80M -26.41M NERV
Operating Income -7.51M -15.37M NERV
ROE -19.4% -9.6% ENTX
ROA -7.9% -9.5% NERV
Total Assets 111.83M 277.04M ENTX
Cash 80.14M 265.88M ENTX
Current Ratio 24.32 128.41 ENTX

Relative Price Performance (Last 90 Days)

NERV 1M: -5.0% · 3M: -48.0% ENTX 1M: +12.3% · 3M: +7.2%

Current Technical Phase

NERV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.0%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $2.30

ENTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 54

RSI (14): 54.1 · Price: $3.11

Fundamentals Snapshot

Metric NERV ENTX
Market Cap — —
Forward P/E -5.5 -7.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -33.83 -0.40
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NERV is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.